Therapeutic neuromodulation: Clinical and research implications of a new therapeutic platform

Psychiatric Annals

Volumn 37, Issue 3, 2007, Pages 165-174

  Demitrack, Mark A ^a,b  

^a Neuronetics   (United States)

^b NeuroStar TMS

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34247521484     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/00485713-20070301-02     Document Type: Review

References (22)

1. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289(23):3095-3105.
2. Trivedi MH, Rush AJ, Wisniewski SR, et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163(1):28-40.
3. Rush AJ, Trivedi MH, Wisniewski SR, et al. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Eng J Med. 2006;354(12):1231-1242.
4. Trivedi MH, Fava M, Wisniewski SR, et al. Medication augmentation after the failure of SSRIs for depression. N Eng J Med. 2006;354(12):1243-1252.
5. Fava M, Rush AJ, Wisniewski SR, et al. A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: A STAR*D Report. Am J Psychiatry. 2006;163(7):1161-1172.
6. Nierenberg AA, Fava M, Trivedi MH, et al. A comparison of lithium and T3 augmentation following two failed medication treatments for depression: a STAR*D Report. Am J Psychiatry. 2006;163(9):1519-1530.
7. McGrath PJ, Stewart JW, Fava M, et al. Tranylcypromine versus venlafaxine plus mirtazapine following three failed anti-depressant medication trials for depression: a STAR*D Report. Am J Psychiatry. 2006;163(9):1531- 1541.
8. Prudic J, Haskett RF, Mulsant B, et al. Resistance to antidepressant medications and shortterm clinical response to ECT. Am J Psychiatry. 1996;153(8):985-992.
9. Prudic J, Olfson M, Marcus SC, et al. Effectiveness of electroconvulsive therapy in community settings. Biol Psychiatry. 2004; 55(3):301-312.
10. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D Report. Am J Psychiatry. 2006;163(11):1905-1917.
11. Rush AJ, Thase ME, Dube S. Research issues in the study of difflcult-to-treat depression. Biol Psychiatry. 2003;53(8):743-753.
12. Sackeim HA. The definition and meaning of treatment resistant depression. J Clin Psychiatry. 2001;62(Suppl 16):10-17.
13. Mayberg HS. Limbic-cortical dysregulation: a Proposed model of depression. J Neuropsychiatry Clin Neurosci. 1997;9(3):471-481.
14. Mayberg HS, Lozano AM, Voon V, et al. Deep brain stimulation for treatment-resistant depression. Neuron. 2005;45(5):651-660.
15. Burt T, Lisanby SH, Sackeim HA. Neuropsychiatric applications of transcranial magnetic stimulation: a meta analysis. Int J Neuropsychopharmacol. 2002;5(1):73-103.
16. Gershon AA, Dannon PN, Grunhaus L. Transcranial magnetic stimulation in the treatment of depression. Am J Psychiatry. 2003;160(5):835-845.
17. Avery DH, Holtzheimer PE, Fawaz W, et al. A controlled study of repetitive transcranial magnetic stimulation in medication-resistant major depression. Biol Psychiatry. 2006;59(2):187-194.
18. Fitzgerald PB, Brown TL, Marston NA, Daskalakis ZJ, De Castella, Kulkarni J. Transcranial magnetic stimulation in the treatment of depression: a double-blind, placebo-controlled trial. Arch Gen Psychiatry. 2003;60(10):1002-1008.
19. Rush AJ, Sackeim HA, Marangell LB, et al. Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study. Biol Psychiatry. 2006;58(5):355-363.
20. Leon AC, Mallinckrodt CH, Chuang-Stein C, Archibald DJ, Archer GE, Chartier K. Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology. Biol Psychiatry. 2006;59(11):1001-1005.
21. Loo CK, Sachdev P, Elsayed H, et al. Effects of a 2-4 week course of repetitive transcranial magnetic stimulation (rTMS) on neuropsychological functioning, electroencephalogram, and auditory threshold in depressed patients. Biol Psychiatry. 2001;49(7):615-623.
22. Loo CK, Taylor JL, Gandevia SC, McDarmont BN, Mitchell PB, Sachdev PS. Transcranial magnetic stimulation (TMS) in controlled treatment studies: are some "sham" forms active? Biol Psychiatry. 2000;47(4):325-331.